Overview

Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
Evaluation of efficacy and safety of SBG vs placebo in the treatment of chronic diabetic foot ulcers.
Phase:
Phase 3
Details
Lead Sponsor:
Biotec Pharmacon ASA